Researchers from South Korea have engineered a strain of bacteria that infiltrates tumors and fools the body’s immune system into attacking cancer cells. In experiments, the modified bacteria worked to reduce cancer in mice, raising hope for human trials.
A wearable patch used to treat peanut allergies has shown tremendous promise in a recently concluded clinical trial, performing particularly well among young children.
It almost sounds too good to be true: Researchers have developed a tiny sponge that can reprogram immune cells to attack cancer. The treatment is less invasive than surgery and potentially more effective, too. And with human trials beginning this week, there's a chance it will soon be available for everyone.
Yesterday, the FDA approved a drug called Provenge. It trains the body's immune system to fight off advanced prostate cancer. It's also the first proof we have that immunotherapy works in the fight against the disease.